Home › Senesco Closes Enrollment in Its Phase 1b/2a SNS01-T Study
 

Keywords :   


Senesco Closes Enrollment in Its Phase 1b/2a SNS01-T Study

2014-08-29 18:04:14| Agriculture - Topix.net

Senesco Technologies, Inc. today announced the closing of enrollment in its ongoing Phase 1b/2a open-label, multiple-dose, dose-escalation clinical trial of SNS01-T, a first-in-class modulator of eukaryotic translation initiation factor 5A , in patients with relapsed or refractory multiple myeloma, plasma cell leukemia or B cell lymphoma.

Tags: study phase closes enrollment

Category:Agriculture and Forestry

Latest from this category

All news
15.11Global beef roundup: Focus on Brazil, Part 2
15.112024 NAPRRS/NC229 session to address emerging swine diseases
15.11Beef, dairy producers invited to Purdue Calving Academy
15.11The long grind
15.11JBS reports strong Q3 financial results
15.11U.S. consumers meat preferences are changing
15.11U.S. consumers meat preferences are changing
15.11Weather and drought update: What's ahead
Agriculture and Forestry »
15.11TOMIX 98693 183B
15.11 6014
15.11WBC L
15.11SHY
15.11 brightMEMORY A1aime
15.11
15.11JOCHUM JO1 LAPONE
15.11
More »